Hussin A. Rothan
Texas Biomedical Research Institute
ORCID: 0000-0002-7300-6388Also affiliated with Biomedical Research Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells”.
Shannon Stone, Janhavi P. Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar +1 more
Arpan Acharya, St Patrick Reid, Mukesh Kumar, Siddappa N. Byrareddy, Hussin A. Rothan
Hussin A. Rothan, Janhavi P. Natekar, Shannon Stone, Heather Pathak, Philip G. Strate +4 more
Shannon Stone, Janhavi P. Natekar, Pratima Kumari, Komal Arora, Mukesh Kumar +1 more
Hussin A. Rothan, Janhavi P. Natekar, Shannon Stone, Heather Pathak, Philip G. Strate +4 more
Hussin A. Rothan, Janhavi P. Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak +4 more
Hussin A. Rothan, Janhavi P. Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak +4 more
Heather Pathak, Shannon Stone, Pratima Kumari, Shaligram Sharma, Tabassum Tasnim Auroni +4 more
Pratima Kumari, Shannon Stone, Janhavi P. Natekar, Komal Arora, Tabassum Tasnim Auroni +2 more
Ramya S. Barre, Anna Allué‐Guardia, Ruby A. Escobedo, Vinay Shivanna, Hussin A. Rothan +10 more